P10 Inc.'s stock plummeted 5.11% on Thursday during the intraday trading session, as the company's strong 2024 performance was overshadowed by concerns around its margin outlook for 2025.
In its Q4 2024 earnings call, P10 reported record fundraising of $3.8 billion, a 23% increase in revenue, and 17% growth in adjusted EBITDA for the full year. The company highlighted the successful closing of its Bon Accord 2 fund, which raised a record $1.6 billion, and its plans to drive further growth through acquisitions like Qualitas Funds, new product launches, and operational efficiencies.
However, analysts expressed concerns about the impact of the Qualitas acquisition on P10's fee-related earnings (FRE) margins in 2025, which the company expects to remain in the mid-40s range. Barclays lowered its price target on P10 to $15 from $16, citing the lower fee rate outlook and potential margin pressure from the Qualitas deal.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。